Molecular Key Found in Diffuse Large B-cell Lymphoma Development
News
A new study has identified the transcription factor FOXP1 as the main regulator in cancer cells’ ability to evade immune responses in patients with diffuse large B-cell lymphomas (DLBCL). The ... Read more